
building something new to empower patients @FlagshipPioneer đ | prev BioxML đ§Ź@LilaSciences @PiN_Harvard @MIT | she/her/dr, views are my own
Joined July 2016
- Tweets1.3K
- Following1.1K
- Followers1K
- Likes11.2K
Maya Jay retweeted
I really wish diagnostics was a better business.
So much need for better solutions. Both the tech itself as well integrating into care that makes them accessible + available. AI doctors + new hardware is interesting here.
Maya Jay retweeted
83% of wearable users check theirs every day.
Yet 55% say their data has never prompted a behaviour change or doctorâs visit, according to @a16z.
Data isnât the same as insight.
With a chronic condition, it can feel even harder:
> You might only see a doctor a few times a year
> Most of what matters happens in between
Thatâs why weâre building @MoyaHealth. Weâre starting with skin conditions, because we know how tough it can be to understand whatâs going on and use your own data to look after your health.
Full report here: a16z.com/the-state-of-longevâŚ
this is...massive. i spent over a 10yrs of my life doing procedures just like this. even after a few years working in AI x Science, i still thought this day was at least 5 years away.
tremendously excited the future of soft robotics and applications for in vivo work
Last night an AI agent performed brain surgery on a mouse.
We gave it 19 gene therapy vectors in a spreadsheet, a mouse model of epilepsy, access to a motorize surgery rig with cameras and one goal: reduce seizures.
It picked the drug. It picked the brain region. It derived the coordinates from three papers. Then it drove the stereotaxic arms into the brain and injected 250 nanolitres while watching the entry site through the rig camera for bleeding.
A licensed vet gated every irreversible step and held a physical kill switch to stop the AI agent.
Thread on what it decided, what it saw, and the moment it refused to let me override it.
[Writing this on the spot out of excitement, but I've been 18hrs in front of my laptop coding and coordinating this, so keeping it brief and descriptive, more cohesive thoughts on this soon...]
Maya Jay retweeted
Neurotech is Humanityâs Next Frontier!
Iâve been investing in neurotech since 2021 and working with teams building BCIs, NeuroAI, and connectomics. It now feels like AI did in ~2019.
We are entering an extraordinary era: neurotech already restores functions, it can enhance our capabilities, and will evolve what it means to be human.
PLC Neurotech is the fund backing the extraordinary founders and defining companies of this booming industry.
If you're in digital(health)(tech), this is the best 40 min watch of the week.
Every conversation we have with @tjparker and the @GeneralMedicine team is a lot of fun. So we recorded one on what it means to build "the healthcare store"
00:00 Intro
00:54 Why health care needs a store
04:51 Getting a biopsy booked in three days
07:13 Lessons from his dadâs pharmacy and PillPack
11:12 Why Amazon Pharmacy was so hard to build
15:40 Why TJ went full-time as CEO
17:10 How do you define a product in healthcare?
20:05 Building a two-sided healthcare marketplace
25:18 How AI works for patients and providers
31:02 Coverage, cash prices and price transparency
37:23 Partnerships and the business model
146
Maya Jay retweeted
Well said Vas. AI will help us conquer disease, but this will take time, effort and lots and lots of data that doesnât exist, yet. I would add that robotic labs will begin to make scaling data more tractable. lnkd.in/p/g8qvP5qX
Wait till they find out how long IACUC takes to approve a protocol amendment to change one number
Where do you go next after reporting from the Strait of Hormuz? For the past three months, Citrini Research, an independent research firm, has been working with our team and an internal research model to see if they could use AI to create a new drug. What follows is an entertaining, candid, and humbling account of a group of motivated nonexperts (or âfilthy casualsâ, as Citrini would say) trying to tackle a real problem in human health with Claude.
We landed on scorpion neurotoxins, which kill over 3,000 people a year. Of the 211 designs we produced and tested, 17 met our criteria for a binder. None of the designs bound more than one toxin and none have been tested for neutralizing a toxin.
One of my favorite quotes from the piece is: âOur virtual biologist may have compressed a year's worth of work into a couple days, but biology works at the speed of lifeâŚOver two days, we watched Claude work through problems at a speed that was difficult to comprehend. For the next two months, we spent much of the time becoming familiar with laboratory turnaround times (This mostly involved sending memes in Slack).â
1
197
Maya Jay retweeted
Itâs been a rough few years in tech for women. still thinking about how much this picture means for all of us, and especially to young women about whatâs possible.
Maya Jay retweeted
sprinkling ai onto legacy healthcare workflows won't magically make care cheaper. to de-escalate the provider-payor arms race, we need to
1) lower the cost of delivering care (e.g. ai doctors) and 2) increase local competition, price transparency, and patient choice
Maya Jay retweeted
As a scientist and biotech founder, I can confidently declare that AGI is here and it's only going to get better.
I haven't quantified my productivity gains precisely and there are different metrics one can evaluate, but overall it feels like a 10-100X improvement.
I know that sounds insane so let me break it down.
I'm working on a 1-to-N case where the goal is to develop an allele-specific knockdown oligo (ASO or siRNA) for a progressive neurological rare pediatric genetic disease.
Unlike previous 1-to-N programs in years past, I can now quarterback the process myself using a tag team of Claude and GPT: one-stop shops for data analysis, hypothesis generation, and consultations on any topic, available at the time and place of my choosing. Critically, I also red team Claude and GPT against each other with identical prompts and file sets.
For example, take oligo design. Admittedly already a computationally native task, but one I would have handed off to an expert. What would have cost $12,000+ and taken a seasoned designer several days to a week of work took me only several natural language prompts and ~$100 and an hour of compute.
From $10,000's of spend to $100's of spend.
From cycle times of days to cycle times of minutes.
I'm not an expert in the disease gene, but I don't need to be. I'm not a trained bioinformatician, but I don't need to be. I'm not a nucleic acids chemist, but ... and so on.
AGI will disproportionately empower the generalists because we no longer have to spend a career or lifetime acquiring domain expertise.
So yes, AI will cures all diseases -- just not overnight. Doesn't feel that way today but we're just at the start of the exponential.
I'd love to hear from other scientists and biotech builders who are using the greatest tool ever created by humanity in their day-to-day battles against a specific disease.
Please share examples of how AGI is helping you become a 100X scientist!
(Props to @DeryaTR_ for leading the way)
I started playing an iPad game for toddlers and decided it had big implications for product design and the way we weaponize curiosity to drive engagement. wrote about it too on my new-ish substack
the world according to pokpok tinyurl.com/3zvpjkck
159
Maya Jay retweeted
the discovery of PCSK9 inhibitors being downstream of finding people with bizarrely low LDL from the Dallas Heart Study implies that a high-value biobank would be one in which the criteria for acceptance is that each participant believes something is deeply wrong with their body
lapsed neuroscientist here coming back out to remind people that
LLMs are not brains
no matter how hard you try to equate the two
deleted this app six months ago and became suspiciously well-adjusted. spent the time building something cool. but i missed strangers' opinions too much.
hello timeline goblins, i'm back to ruin all that progress with you
(will explain the thing eventually, goblin's honor)
1
6
285
Maya Jay retweeted
Awesome list @chrisbarber! @LilaSciences is hiring across a ton of areas including RL, infra, ML Ops, ML for bio and materials. If youâre at NeurIPS please reach out or come join us at our happy hour!
RSVP: luma.com/LilaNeurIPS2025
A big chunk of the team will be there and will be a great opportunity to learn more about Lila
I made an unofficial NeurIPS 2025 hiring list:
@rronak_, @QuantumArjun, @michaelelabd, stealth, Iâm a small investor: RL post-training from live product usage. Research Engineers.
@jonsid, Turing: data for frontier models. Research Engineers, SWEs.
@schwarzjn_, ICL & Thomson Reuters: LLMs for law. Research Engineers, SWEs, PhD students.
@panda_liyin, AdaL: copilot for ML engineering. MLEs, SWEs.
@sarwal_varuni, TriFetch: data and post-training for medical AI.
@bidhan, Bagel Labs: decentralized training for diffusion models. MLEs, ML Scientists.
@meggmcnulty, Cosmic Labs: AI-native OS for embedded engineering. MLEs, SWEs, systems engineers.
@samuelekpe, GrupaAI: operating system for AI agents. SWEs.
@jaradcannon, Humanoid: industrial humanoids. SWEs and applied researchers.
@saurabh_here1, Cantina: AI native social media. Research interns for video gen.
@RicardoMonti9, DatologyAI: frontier data curation (filtering, mixing, synthetic) for LLMs. Research Scientists, MLEs, SWEs.
@NimaGard, Path Robotics: physical AI to automate manufacturing tasks (e.g. welding). MLEs for robot learning.
@DrJimFan, Nvidia robotics team. Research Engineers, SWEs.
@katherine1ee, OpenAI pretraining safety team. Research Engineers.
@BorisMPower, OpenAI applied AI research team. Research Engineers.
@j_asminewang, OpenAI alignment team. Research Engineers, Research Scientists.
@zijianwang30, MSL data research team. Research Engineers, Research Scientists.
@RuiqiGao, Google DeepMind video gen team. Research Engineers, Research Scientists.
@joshim5, Chai Discovery: molecule prediction for drug discovery. Research Engineers, SWEs.
@crisbodnar, Project Prometheus: AI for manufacturing and logistics. Research Engineers.
@vdbergrianne, Microsoft Research Amsterdam materials science team. Research Engineers.
@kamath_sutra, Smallest: AI for call centers. SWEs.
@idavidrein, METR: frontier model evaluation. Research Engineer.
@jimmysmith1919, Liquid AI: on-device models. MLEs, Research Engineers.
@alxndrdavies, AI Security Institute: red-teaming. Research Scientists/Engineers.
@stuhlmueller, Elicit: AI for scientific research and good reasoning. MLEs, SWEs.
@gavincrooks, @FarisSbahi, Normal Computing: physics-based ASICs. Research Engineers, SWEs.
@myra_deng, Goodfire AI: interpretability research. Research Engineers, Research Scientists, MLEs.
@_lychrel, @SergeiIakhnin, @ja_kirkpatrick, @sbos, Isomorphic Labs: AI-first drug discovery. Research Engineers, Research Scientists, MLEs.
@kdqg1, @bneyshabur, Anthropic AI Scientist team. Research Engineers with infra experience.
@sarahookr, Adaption: continuous learning. Research Engineers.
@francedot, Cua, Iâm a small investor: infra for computer-use agents. SWEs, Research Engineers.
@iScienceLuvr, Sophont: multimodal models for healthcare. Research Engineers/Research Scientists.
@aditshah00, Until Labs: organ preservation. MLEs.
@RitvikKapila & @gauri__gupta, NeoSigma: evals and post-training for real world agents. SWEs.
@abeirami, stealth: reliability & statistical evaluation. Research Engineers & SWEs.
@adityachinchure, Ideogram: image generation. Research Engineers.
@AndrewLBeam, @kenneth0stanley, Lila Sciences: autonomous labs, verifiability for science. Research Engineers, MLEs.
@brianwilt, Waymo: ML infra for motion planning team. Senior SWEs.
@thisismadani, Profluent Bio: protein generation for drug development. MLEs.





















